Eli Lilly and Co
NYSE:LLY

Watchlist Manager
Eli Lilly and Co Logo
Eli Lilly and Co
NYSE:LLY
Watchlist
Price: 786.23 USD -3.15% Market Closed
Market Cap: 747.3B USD
Have any thoughts about
Eli Lilly and Co?
Write Note

Eli Lilly and Co
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Eli Lilly and Co
Cash Equivalents Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
ZTS

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Eli Lilly and Co
NYSE:LLY
Cash Equivalents
$3.4B
CAGR 3-Years
-4%
CAGR 5-Years
17%
CAGR 10-Years
1%
Johnson & Johnson
NYSE:JNJ
Cash Equivalents
$4.8B
CAGR 3-Years
32%
CAGR 5-Years
27%
CAGR 10-Years
-10%
Bristol-Myers Squibb Co
NYSE:BMY
Cash Equivalents
$7.9B
CAGR 3-Years
-16%
CAGR 5-Years
-24%
CAGR 10-Years
5%
Pfizer Inc
NYSE:PFE
Cash Equivalents
$1.1B
CAGR 3-Years
-19%
CAGR 5-Years
-18%
CAGR 10-Years
-8%
Merck & Co Inc
NYSE:MRK
Cash Equivalents
$14.6B
CAGR 3-Years
13%
CAGR 5-Years
13%
CAGR 10-Years
3%
Zoetis Inc
NYSE:ZTS
Cash Equivalents
$1.7B
CAGR 3-Years
-19%
CAGR 5-Years
-1%
CAGR 10-Years
11%

See Also

What is Eli Lilly and Co's Cash Equivalents?
Cash Equivalents
3.4B USD

Based on the financial report for Sep 30, 2024, Eli Lilly and Co's Cash Equivalents amounts to 3.4B USD.

What is Eli Lilly and Co's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
1%

Over the last year, the Cash Equivalents growth was 41%. The average annual Cash Equivalents growth rates for Eli Lilly and Co have been -4% over the past three years , 17% over the past five years , and 1% over the past ten years .

Back to Top